{"data":[{"accessionNo":"0001968582-26-000272","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.V.","ticker":"NAMS","personName":"Louis G. Lange","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":44619,"aggregateMarketValue":1395236.13,"unitsOutstanding":114975422,"approxSaleDate":"2026-03-11","exchange":"Nasdaq","filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-26-000241","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.V.","ticker":"NAMS","personName":"Louis G. Lange","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":28186,"aggregateMarketValue":878839.48,"unitsOutstanding":114975422,"approxSaleDate":"2026-03-06","exchange":"Nasdaq","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-26-000230","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.V.","ticker":"NAMS","personName":"Kastelein Johannes Jacob Pieter","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":300000,"aggregateMarketValue":9354000,"unitsOutstanding":114975422,"approxSaleDate":"2026-03-02","exchange":"Nasdaq","filedAt":"2026-03-05","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-26-000187","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.V.","ticker":"NAMS","personName":"Michael H. Davidson","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":443707,"aggregateMarketValue":15733850.22,"unitsOutstanding":114975422,"approxSaleDate":"2026-03-02","exchange":"Nasdaq","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-26-000152","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.V.","ticker":"NAMS","personName":"Michael H. Davidson","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":750000,"aggregateMarketValue":27127500,"unitsOutstanding":114975422,"approxSaleDate":"2026-02-24","exchange":"Nasdaq","filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0002085929-26-000002","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co N.V.","ticker":"NAMS","personName":"Kastelein Johannes Jacob Pieter","relationship":"Officer, Director","securityClass":"Ordinary shares, nominal value EUR 0.12 per share","broker":"ABN AMRO","unitsToSell":45481,"aggregateMarketValue":1575007.03,"unitsOutstanding":114975422,"approxSaleDate":"2026-02-20","exchange":"Nasdaq Global Market","filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-26-000040","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.A.","ticker":"NAMS","personName":"Mayur Somaiya","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":200000,"aggregateMarketValue":6330000,"unitsOutstanding":113390804,"approxSaleDate":"2026-01-20","exchange":"Nasdaq","filedAt":"2026-01-20","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001974494-26-000023","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co. N.V.","ticker":"NAMS","personName":"Michael Davidson","relationship":"affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":11582,"aggregateMarketValue":410888.61,"unitsOutstanding":113390000,"approxSaleDate":"2026-01-07","exchange":"NASDAQ","filedAt":"2026-01-07","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-26-000015","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.V.","ticker":"NAMS","personName":"Douglas F Kling","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":300000,"aggregateMarketValue":10044000,"unitsOutstanding":113390804,"approxSaleDate":"2026-01-06","exchange":"Nasdaq","filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001974494-26-000013","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co. N.V.","ticker":"NAMS","personName":"Mayur Ian Somaiya","relationship":"affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":5118,"aggregateMarketValue":170172.71,"unitsOutstanding":113390000,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001974494-26-000017","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co. N.V.","ticker":"NAMS","personName":"Louise Kooij","relationship":"affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":2647,"aggregateMarketValue":88012.34,"unitsOutstanding":113390000,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001974494-26-000015","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co. N.V.","ticker":"NAMS","personName":"Johannes Kastelein","relationship":"Affiliate","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":6000,"aggregateMarketValue":199499.07,"unitsOutstanding":113390000,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001968582-25-001282","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Company N.A.","ticker":"NAMS","personName":"Louise Kooij","relationship":"Officer","securityClass":"Ordinary Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":290000,"aggregateMarketValue":10582100,"unitsOutstanding":113390804,"approxSaleDate":"2025-12-23","exchange":"NASDAQ","filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001193125-25-305720","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co N.V.","ticker":"NAMS","personName":"Bain Capital Life Sciences Fund II, L.P.","relationship":"Former Affiliate","securityClass":"Ordinary Shares","broker":"Goldman Sachs & Co. LLC","unitsToSell":267429,"aggregateMarketValue":10250554,"unitsOutstanding":113390804,"approxSaleDate":"2025-12-02","exchange":"Nasdaq","filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0001193125-25-305717","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co N.V.","ticker":"NAMS","personName":"BCLS II Investco, LP","relationship":"Former Affiliate","securityClass":"Ordinary Shares","broker":"Goldman Sachs & Co. LLC","unitsToSell":4500000,"aggregateMarketValue":172485000,"unitsOutstanding":113390804,"approxSaleDate":"2025-12-02","exchange":"Nasdaq","filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/nams"},{"accessionNo":"0000950130-25-000295","issuerCik":"0001936258","issuerName":"NewAmsterdam Pharma Co N.V.","ticker":"NAMS","personName":"BCIP Life Sciences Associates, LP","relationship":"Former Affiliate","securityClass":"Ordinary Shares","broker":"Goldman Sachs & Co. LLC","unitsToSell":32571,"aggregateMarketValue":1248446,"unitsOutstanding":113390804,"approxSaleDate":"2025-12-02","exchange":"Nasdaq","filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/nams"}],"updatedAt":"2026-11-03T17:50:06.713Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/nams","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}